Researchers have found that a new vaccine strategy tested in mice provides stronger, more long-lasting protection from tuberculosis infection than the vaccine currently used in humans, known as BCG.
Researchers have found that a new vaccine strategy tested in mice provides stronger, more long-lasting protection from tuberculosis infection than the vaccine currently used in humans, known as BCG.